Abstract:Objective To investigate the influence of low calcium dialysate (DCa1.25) and midodrine hydrochloric (MHC) on blood pressure in hemodialysis patients. Methods Dialysate calcium concentration was changed from 1.5% (DCa1.5) to 1.25% in patients with hypercalcaemia pre- or post-dialysis.For patients with intradialytic hypotension(IDH), pre-dialysis antihypertensive drugs were ceased.If that didn′t work, MHC 2.5 or 5 mg was administered to them 30 minutes before dialysis were ceased.MHC was also administered to patients who had not taken antihypertensive drugs. The blood pressure (BP) and blood volume were recorded during dialysis. UCG and autonomic nerves function test including BP supine and standing test and sustained hand-grip test were measured as well. Results Twenty-one hemodialysis patients were involved in this study including male 9 and female 12. The average age was (54.4±14.2) years old,the time on dialysis (33.04±30.1) months. When DCa1.5 was changed to DCa1.25, 9 cases (42.9%) could maintain stable BP, but IDH occurred in 10 patients(47.6%) with symptoms such as swirl,sweat or cramp, one with lower extremities cramp and one with heart discomfort but without IDH. Patients with IDH had higher proportion of abnormal BP supine and standing tests compared with patients without IDH(50% vs. 0%, P 0.05). No difference in other clinical characteristics and UCG results existed between two groups. Five patients with IDH were administered MHC pre-dialysis, whose blood volume significantly decreased in DCa1.25 compared to DCa1.5Influence of low calcium dialysate and midodrine hydrochloride on blood pressure in hemodialysis patients$$$$ DONG Jie, WANG Mei, ZUO Li, JIANG Qi. Renal Division, The First Hospital, Peking University, Beijing 100034, ChinaAbstract Objective To investigate the influence of low calcium dialysate (DCa1.25) and midodrine hydrochloric (MHC) on blood pressure in hemodialysis patients. Methods Dialysate calcium concentration was changed from 1.5% (DCa1.5) to 1.25% in patients with hypercalcaemia pre- or post-dialysis.For patients with intradialytic hypotension(IDH), pre-dialysis antihypertensive drugs were ceased.If that didn′t work, MHC 2.5 or 5 mg was administered to them 30 minutes before dialysis were ceased.MHC was also administered to patients who had not taken antihypertensive drugs. The blood pressure (BP) and blood volume were recorded during dialysis. UCG and autonomic nerves function test including BP supine and standing test and sustained hand-grip test were measured as well. Results Twenty-one hemodialysis patients were involved in this study including male 9 and female 12. The average age was (54.4±14.2) years old,the time on dialysis (33.04±30.1) months. When DCa1.5 was changed to DCa1.25, 9 cases (42.9%) could maintain stable BP, but IDH occurred in 10 patients(47.6%) with symptoms such as swirl,sweat or cramp, one with lower extremities cramp and one with heart discomfort but without IDH. Patients with IDH had higher proportion of abnormal BP supine and standing tests compared with patients without IDH(50% vs. 0%, P 0.05). No difference in other clinical characteristics and UCG results existed between two groups. Five patients with IDH were administered MHC pre-dialysis, whose blood volume significantly decreased in DCa1.25 compared to DCa1.5[(81.6±2.09)% vs (86.18±2.38)%, P 0.05). Furthermore, the blood volume in patients receiving HCM with DCa1.25 was markedly higher than that with DCa1.25 only[(85.96±3.10)% vs(81.6±2.09)%, P 0.05). Conclusions IDH occurs in about 50% of 21 cases with DCa1.25, who have more severe automatic dysfunction than those with stable BP. In patients with IDH,antihypertensive drugs can be ceased or MHC can be administered before dialysis.MHC can increase blood volume through enhancing peripheral vessels resistance and then effectively maintain stable BP.

Clinical analysis of intradialytic hypertension in maintenance hemodialysis patients

Evaluation of Intradialytic Hypertension Using Bioelectrical Impedance Combined With Echocardiography in Maintenance Hemodialysis Patients

A study on the risk factors for intradialytic-hypotension among maintenance hemodialysis patients

Cross-sectional Study on Prevalence and Related Factors of Intradialytic Hypertension

THE PREVALENCE OF INTRADIALYTIC HYPOTENSION UNDER DIFFERENT DIAGNOSTIC CRITERIA AND ITS ASSOCIATION WITH MORTALITY

Control of Hypertension and Factors Relating to Hypertension in Maintenance Hemodialysis Patients

Analysis on the occurrence and influencing factors of frequent intradialytic hypotension in hemodialysis patients

Intradialytic Hypotension As an Independent Risk Factor for 5-Year Mortality in Maintaining Hemodialysis Patients

Recent Advances in Clinical Research of Intradialytic Hypotension

Influence of low calcium dialysate and midodrine hydrochloride on blood pressure in hemodialysis patients

The relationship between prescription of ultrafiltration and intradialytic hypotension in Chinese hemodialysis patients.

Effects of diuretics on intradialytic hypotension in maintenance dialysis patients: a systematic review and meta-analysis

Intradialytic Hypotension as an Independent Risk Factor for Long-Term Mortality in Maintaining Hemodialysis Patients: A 5-Year Follow-Up Cohort Study

A multicenter investigation of hypertension treatment in patients with maintenance hemodialysis

Hypertension in Maintenance Hemodialysis Patients and Advances in Its Treatment

Risk Factors Evaluation of Hypertension in Patients with Maintenance Hemodialysis

Effect of higher calcium concentration in dialysate on hemodynamics in intra-dialytic hypotension patients:a cross-over and self-control trial

Higher atherogenic index of plasma is associated with intradialytic hypotension: a multicenter cross-sectional study

Inappropriately elevated endothelin-1 plays a role in the pathogenesis of intradialytic hypertension

Role Of Magnesium In The Risk Of Intradialytic Hypotension Among Maintenance Hemodialysis Patients

Factors Associated with Poorly-Controlled Hypertension in Maintenance Hemodialysis Patients